Ocean Biomedical Inc. (OCEA)
0.62
-0.06 (-9.32%)
At close: Jan 14, 2025, 3:59 PM
0.61
-0.85%
After-hours Jan 14, 2025, 06:01 PM EST
undefined% (undefined)
| Bid | 0.6 |
| Market Cap | 21.59M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.62 |
| Volume | 62,007 |
| Avg. Volume (20D) | 239,596 |
| Open | 0.67 |
| Previous Close | 0.68 |
| Day's Range | 0.60 - 0.67 |
| 52-Week Range | 0.46 - 7.79 |
| Beta | undefined |
About OCEA
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol OCEA
Website http://www.oceanbiomedical.com
Analyst Forecast
According to 2 analyst ratings, the average rating for OCEA stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 0.00%
